Marsico Capital Management LLC Natera, Inc. Transaction History

Marsico Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$30.32 - $91.33 $256,780 - $773,473	8,469 Added 14.62%	66,404 $2.7 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $1.14 Million - $1.58 Million	-13,265 Reduced 18.63%	57,935 $5.41 Million
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $3.33 Million - $4.2 Million	33,246 Added 87.6%	71,200 $7.94 Million
Q3 2020 Nov 13, 2020	BUY	$45.89 - $72.67 $1.74 Million - $2.76 Million	37,954 New	37,954 $2.74 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Marsico Capital Management LLC with notifications on news.